Syngenta CEO Targets Seeds as Top M&A Priority

The transcript discusses Syngenta's merger with CHEM China, highlighting the strategic benefits and challenges of expanding in China. It covers increased R&D investments, innovation, and the importance of the Chinese market. The discussion also touches on competition with Bayer Monsanto, M&A strategies, and the role of leadership in navigating global trade relations, particularly amid US-China tensions.

What has been the biggest opportunity for Syngenta since the merger with CHEM China?

How much does Syngenta spend annually on research and development?

How does Syngenta view the allegations of China stealing innovation technology?

In what ways has Syngenta benefited from being part of a Chinese company?

What is the significance of the Bayer Monsanto deal for Syngenta?

What are some of the areas where Syngenta is looking to strengthen its position?

What is Syngenta's strategy regarding acquisitions in the next year?